Inovio to present at the jefferies 2021 virtual healthcare conference

Plymouth meeting, pa., may 25, 2021 /prnewswire/ -- inovio (nasdaq:ino) a biotechnology company focused on bringing to market precisely designed dna medicines to treat and protect people from infectious diseases, cancer, and hpv-associated diseases, announced today that dr. joseph kim, president and ceo, is scheduled to participate in a fireside chat and 1x1 investor meetings at the jefferies 2021 virtual healthcare conference on tuesday, june 1, 2021 at 2:00 pm edt.
INO Ratings Summary
INO Quant Ranking